{"id":2213,"date":"2026-10-07T20:53:29","date_gmt":"2026-10-07T20:53:29","guid":{"rendered":"https:\/\/health.myinstants39.com\/serum-institutes-hpv-vaccine-cervavac-receives-who-prequalification\/"},"modified":"2026-10-07T20:53:29","modified_gmt":"2026-10-07T20:53:29","slug":"serum-institutes-hpv-vaccine-cervavac-receives-who-prequalification","status":"publish","type":"post","link":"https:\/\/healthcare.hibisports.com\/serum-institutes-hpv-vaccine-cervavac-receives-who-prequalification\/","title":{"rendered":"Serum Institute\u2019s HPV vaccine Cervavac receives WHO prequalification"},"content":{"rendered":"<div class=\"schemaDiv\" id=\"schemaDiv\">\n<p>Serum Institute of India\u2019s recombinant Quadrivalent Human Papillomavirus vaccine (qHPV) vaccine Cervavac has received World Health Organization (WHO) prequalification.<\/p>\n<p>The vaccine targets HPV types 6, 11, 16, and 18. It is indicated for girls and boys aged 9 through 26 years. Inclusion on the WHO list of prequalified vaccines allows Cervavac to be procured by United Nations agencies, Serum Institute said.<\/p>\n<div class=\"also-read print-hide\" data-ga-label=\"AlsoReadArticle\">\n<div class=\"element\">\n<div class=\"title\">\n\t\t\t\t\t\t\t\t\t\tSerum\u2019s HPV vaccine non-inferior to Gardasil: study<\/div>\n<div class=\"picture\"><img decoding=\"async\" src=\"https:\/\/th-i.thgim.com\/public\/news\/national\/dh3hpt\/article67829502.ece\/alternates\/SQUARE_1200\/Cervavac%20photo.jpg\" data-src-template=\"https:\/\/th-i.thgim.com\/public\/news\/national\/dh3hpt\/article67829502.ece\/alternates\/SQUARE_80\/Cervavac%20photo.jpg\" data-original=\"https:\/\/www.thehindu.com\/theme\/images\/th-online\/1x1_spacer.png\" alt=\"\" data-device-variant=\"SQUARE~SQUARE~SQUARE~SQUARE\" class=\"media-object lazy adaptive placeholder lazy\" width=\"100%\" height=\"100%\"><\/div>\n<\/div>\n<\/div>\n<p>The vaccine was developed in collaboration with the Department of Biotechnology (DBT) and the Biotechnology Industry Research Assistance Council (BIRAC), along with the WHO-IARC (International Agency for Research on Cancer) and the Gates Foundation. It is the 32nd WHO prequalification for products\/biologicals received by Serum Institute, the vaccine maker said.<\/p>\n<p>\u201cWHO prequalification of Cervavac is an important step in strengthening the global response to HPV. We are pleased to see this indigenously developed vaccine reach this achievement,\u201d CEO Adar Poonawalla said.<\/p>\n<div class=\"also-read print-hide\" data-ga-label=\"AlsoReadArticle\">\n<div class=\"element\">\n<div class=\"title\">\n\t\t\t\t\t\t\t\t\t\t\u2018Free\u2019 vaccines, single-dose nudge pushes India-made HPV vaccine to back of the line<\/div>\n<div class=\"picture\"><img decoding=\"async\" src=\"https:\/\/th-i.thgim.com\/public\/incoming\/829i8i\/article70706817.ece\/alternates\/SQUARE_1200\/PTI02_28_2026_000631A.jpg\" data-src-template=\"https:\/\/th-i.thgim.com\/public\/incoming\/829i8i\/article70706817.ece\/alternates\/SQUARE_80\/PTI02_28_2026_000631A.jpg\" data-original=\"https:\/\/www.thehindu.com\/theme\/images\/th-online\/1x1_spacer.png\" alt=\"\" data-device-variant=\"SQUARE~SQUARE~SQUARE~SQUARE\" class=\"media-object lazy adaptive placeholder lazy\" width=\"100%\" height=\"100%\"><\/div>\n<\/div>\n<\/div>\n<h4 class=\"sub_head\">Approved for use in India by DCGI<\/h4>\n<p>Cervavac has been approved for use in India by the Drugs Controller General of India (DCGI). The vaccine is administered for the prevention of diseases caused by the four HPV types \u2014 prevention of anal cancer in boys and young men, and cervical, vulvar, vaginal, and anal cancers in girls and young women. It is also indicated in preventing genital warts, as applicable to the indicated population.<\/p>\n<p>The vaccine is administered intramuscularly and available in 1-dose vials of 0.5 ml and 2-dose vials of 1.0 ml presentations.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Inclusion on the WHO list allows Cervavac to be procured by U.N. agencies. The vaccine targets four HPV types and is indicated for girls and boys aged 9 through 26 years<\/p>\n","protected":false},"author":1,"featured_media":2625,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["post-2213","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/healthcare.hibisports.com\/wp-json\/wp\/v2\/posts\/2213","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/healthcare.hibisports.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/healthcare.hibisports.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/healthcare.hibisports.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/healthcare.hibisports.com\/wp-json\/wp\/v2\/comments?post=2213"}],"version-history":[{"count":0,"href":"https:\/\/healthcare.hibisports.com\/wp-json\/wp\/v2\/posts\/2213\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/healthcare.hibisports.com\/wp-json\/wp\/v2\/media\/2625"}],"wp:attachment":[{"href":"https:\/\/healthcare.hibisports.com\/wp-json\/wp\/v2\/media?parent=2213"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/healthcare.hibisports.com\/wp-json\/wp\/v2\/categories?post=2213"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/healthcare.hibisports.com\/wp-json\/wp\/v2\/tags?post=2213"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}